Broaden your applications with magnetic bead conjugation

Speaker

Abstract
Magnetic beads (or superparamagnetic particles) are one of the most versatile tools in molecular biology for easy and effective isolation of biomolecules. They incorporate tiny (20 to 30 nm) particles of iron oxides, such as magnetite (Fe3O4), which give them superparamagnetic properties. Whether you are purifying antibodies from a crude extract, coating beads with specific antibodies, or binding targets to the beads, it is important to choose a bead that suits your application. Sometimes, the required chemistry is not readily available or does not perform as intended and it is necessary to modify the magnetic properties, coatings or functional groups through customization or conjugation.
 
Join our webinar hosted by Tom Lyons (MChem) to discuss the technology behind magnetic bead chemistry and the advantages of conjugation and customization to optimize results. From protein and nucleic acid sample preparation to labeling and detection products, hear how these modifications can streamline your genomics workflow and expand your molecular diagnostic applications.
 
Learning objectives
  • Discuss the technology behind magnetic bead chemistry
  • Understand the range of surface chemistries and sizes available to meet different application requirements
  • Review how magnetic bead customization and conjugation can help to streamline the genomics workflow and expand the range of molecular diagnostic applications available

Show Resources
You May Also Like
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
APR 07, 2021 9:00 AM PDT
C.E. CREDITS
APR 07, 2021 9:00 AM PDT
One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...
C.E. CREDITS
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with multiple motor and non-motor symptoms. PD is characterized by the presence on proteinaceous neuronal...
Loading Comments...
Show Resources